Climate Health Medical

Hype and disputes surrounding blood pressure measurement

HQ Team October 17, 2024: Blood pressure measurement is a critical procedure in diagnosing and managing hypertension, yet it is fraught with scientific.

Read More
Drugs Health Pharma

New cardiovascular risk calculator may impose a burden on 16 million US citizens

HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the.

Read More
Climate Health Medical

Commute-linked air pollution has alarming Impact on blood pressure

HQ Team November 30, 2023: Rush hour traffic is an everyday reality for most city dwellers. Adding to the frustration of being stuck.

Read More
Drugs Health Pharma

Opinion: Feast for G20 leaders, benefits of millets exceed rice, wheat

By Dr. K. Leelamoni November 30, 2023: The move to serve Indian millet-based food, to G20 leaders in New Delhi in September 2023.

Read More
Drugs Health Pharma

Reducing salt intake leads to decline in blood pressure: US study  

HQ Team November 14, 2023: Lowering sodium intake can reduce blood pressure regardless of whether one is on medication, a study reveals. Researchers.

Read More
Health Medical Pharma

Using mobile phones for 30 minutes a week ups blood pressure: Study

HQ Team May 5, 2023: People who talk on their cellphones for more than 30 minutes a week risk a 12% increase in.

Read More
Drugs Medical Pharma

Merck says trial hypertension drug enhances patients’ walk time

Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.

Read More
Health Medical Pharma

Excessive salt in your diet may harm immune system, scientists say

Too much salt in your diet may be bad for your blood pressure and the cardiovascular system, but global research done by a.

Read More
Drugs Pharma

AstraZeneca to acquire US-based CinCor for $1.8 billion

AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.

Read More